Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:30 AM
Ignite Modification Date:
2025-12-25 @ 4:30 AM
NCT ID:
NCT05628818
Eligibility Criteria:
Inclusion Criteria:
* Clinical and radiological diagnosis, by means of cranial MRI or CT scan, of ischemic/hemorrhagic stroke, involving the frontal cortex or its subcortical connections (basal ganglia), in one or both hemispheres.
* The stroke occurred during the 3 months prior to inclusion in the study.
* Cognitive impairment with a dis-executive profile demonstrated by a score \> 26 in the Spanish version of the MoCA test, adjusted for the number of years of formal education.
* Patients with functional independence prior to the stroke, defined as a modified rankin scale score \< 3 points.
* The patient gives informed consent.
Exclusion Criteria:
* Presence of other pathologies that may be a potential cause of disability or cognitive impairment.
* Moderate or severe aphasia that hinders communication.
* Severe sensory and/or motor impairments that prevent the completion of the evaluation and/or intervention processes.
* Presence of extensive vascular leukopathia (leukoaraiosis grade 3, 4).
* History of epilepsy or seizures.
* Presence of severe systemic pathology, including cardiac, hepatic or renal failure, active neoplasia.
* Failure to meet any of the inclusion criteria recorded in the Screening for electrical stimulation of the University of Göttingen.
* Presence of:
1. Pacemaker.
2. Electrical and/or metallic implants.
3. Pregnancy.
4. Anticonvulsant medication.
5. Tattoos in the area of electrode placement.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT05628818
Study Brief:
Protocol Section:
NCT05628818